Evidence map›Paper›PMID 38674596›Full record

ArticleMicroorganisms2024

Optimization of Culture Conditions and Batch Process Control for the Augmented Production of Bacteriocin by

Ahmed M Elazzazy, Mona O Mobarki, Afra M Baghdadi, Noor M Bataweel, Ahmed M Al-Hejin

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Innovations in process engineering approaches for enhanced bacteriocin production.Journal of industrial microbiology & biotechnology · 2026
    Review
  3. Investigating a newBiotechnology reports (Amsterdam, Netherlands) · 2025
    Article
  4. Article
  5. A Novel NeotropicalMicroorganisms · 2025
    Article
  6. Review
  7. Optimisation of cultivation conditions forFrontiers in pharmacology · 2025
    Article
  8. Antibacterial Activity and Cytotoxicity of the Novel Bacteriocin Pkmh.International journal of molecular sciences · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ahmed M ElazzazyDepartment of Biological Sciences, College of Science, University of Jeddah, P.O. Box 80327, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-9917-1082
Mona O MobarkiDepartment of Biological Sciences, College of Science, University of Jeddah, P.O. Box 80327, Jeddah 21589, Saudi Arabia.
Afra M BaghdadiDepartment of Biological Sciences, College of Science, University of Jeddah, P.O. Box 80327, Jeddah 21589, Saudi Arabia.
Noor M BataweelKing Fahad Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
Ahmed M Al-HejinKing Fahad Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
University of Jeddah · SAKing Abdulaziz University · SA

Funding

This work was funded by the University of Jeddah, Jeddah, Saudi Arabia, under grant No. (UJ-23-DR-253). Therefore, the authors thank the Uni-versity of Jeddah for its technical and financial support. UJ-23-DR-253
6 · The paper itself

Abstract

The emergence of antibiotic-resistant microorganisms poses a significant threat to human health worldwide. Recent advances have led to the discovery of molecules with potent antimicrobial activity from environmental sources. In this study, fifteen bacterial isolates were obtained from agricultural and polluted soil samples collected from different areas of the cities of Jizan and Jeddah. These isolates were screened for antagonistic activity against a set of human pathogenic bacterial strains. The results showed that two

Indexed as

antimicrobial peptidesBacillus amyloliquefaciensBacillus atrophaeusbacteriocinbatch processbioreactorPCRrhizosphere

Identifiers

PMID38674596
PMCPMC11051734
OpenAlexW4393164250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.